|
Ed joined Alta Partners in 2002 and is a Director in Alta Partners BioPharma III fund. From 1997 to 2001, Ed served as Senior Vice President and Chief Financial Officer of Affymetrix, a publicly held life sciences company. From 1994 to 1997, Ed was a biotechnology research analyst for Robertson Stephens & Company, and from 1992 to 1994, was a biotechnology research analyst for Smith Barney Shearson. From 1990 to 1992, Ed practiced commercial law at Cooley Godward LLP. He is currently on the board of directors of MacroGenics, and led Alta's investments in ChemoCentryx, Threshold Pharmaceuticals and Sunesis.
Ed earned his Juris Doctor and Master of Business Administration degrees in 1990 from the University of California, Berkeley’s Boalt School of Law and Haas School of Business, respectively. Ed earned a Bachelor of Arts in Molecular Biology from Cornell University in 1985. | 